About this trial
Dementia is observed in 80% of people living with advanced stage Parkinson's disease, however, there are inadequate opportunities for early and effective diagnosis of dementia in current clinical practice. This study aims to identify whether a new tool called PDCogniCare, can improve detection of dementia in people living with Parkinson's disease, and to explore what factors might influence its use in healthcare services.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
People living with idiopathic Parkinson's disease, one year or more post-diagnosis, attending Movement Disorder Clinics
Disqualifiers
People with severe Parkinson's disease who aren't able to communicate
People with comorbid neurological conditions (e.g. Stroke)
Trial design
Single group
Treatments tested in this trial
PDCogniCare platform
Other interventionDigital platform designed to support early and accurate detection of dementia in people living with Parkinson's disease
Treatment groups
Trial outcomes
Primary outcomes
Change in percentage of people with Parkinson's disease diagnosed with dementia
Secondary outcomes
Change in percentage of people with Parkinson's disease diagnosed with mild cognitive impairment
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
The University of Queensland
Lead sponsor
Medical Research Future Fund
Collaborator
Metro South Health
Collaborator
Metro North Health
Collaborator
Queensland University of Technology
Collaborator
University of Sydney
Collaborator
OPN365
Collaborator
Australian Dementia Network
Collaborator
Dementia Australia
Collaborator
Lions Club of Brisbane Inner North
Collaborator
Parkinson's Queensland
Collaborator
This trial is not recruiting at the moment. You can still explore other options: